Prognostic Value of <sup>18</sup>F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy.

Zhang, Jingjing; Liu, Qingxing; Singh, Aviral; Schuchardt, Christiane; Kulkarni, Harshad R; Baum, Richard P

Prognostic Value of ¹⁸F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy.

Zhang, Jingjing; Liu, Qingxing; Singh, Aviral; Schuchardt, Christiane; Kulkarni, Harshad R; Baum, Richard P.

Afiliação

Zhang J; Theranostics Center for Molecular Radiotherapy and Precision Oncology, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany zhangjingjingtag@163.com.
Liu Q; Theranostics Center for Molecular Radiotherapy and Precision Oncology, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.
Singh A; Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; and.
Schuchardt C; Theranostics Center for Molecular Radiotherapy and Precision Oncology, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.
Kulkarni HR; GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.
Baum RP; Theranostics Center for Molecular Radiotherapy and Precision Oncology, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

J Nucl Med ; 61(11): 1560-1569, 2020 11.

Article em En | MEDLINE | ID: mdl-32169914

Assuntos

Fluordesoxiglucose F18; Tumores Neuroendócrinos/diagnóstico por imagem; Tumores Neuroendócrinos/radioterapia; Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada/métodos; Compostos Radiofarmacêuticos/uso terapêutico; Somatostatina/análogos & derivados; Adulto; Idoso; Idoso de 80 Anos ou mais; Estudos de Coortes; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Metástase Neoplásica; Tumores Neuroendócrinos/mortalidade; Tumores Neuroendócrinos/patologia; Octreotida/análogos & derivados; Octreotida/uso terapêutico; Compostos Organometálicos/uso terapêutico; Prognóstico; Receptores de Somatostatina/metabolismo; Somatostatina/uso terapêutico

Palavras-chave

177Lu; 18F-FDG; 90Y; neuroendocrine neoplasms; peptide receptor radionuclide therapy; prognostic factor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Somatostatina / Tumores Neuroendócrinos / Compostos Radiofarmacêuticos / Fluordesoxiglucose F18 / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google